Braidwell’s Zura Bio ZURA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$23.5M Sell
3,980,295
-8,694
-0.2% -$41.4K 0.87% 47
2026
Q1
$23.7M Buy
3,988,989
+808,600
+25% +$4.88M 0.79% 50
2025
Q4
$16.7M Buy
3,180,389
+707,583
+29% +$2.8M 0.53% 56
2025
Q3
$10.7M Hold
2,472,806
0.32% 65
2025
Q2
$2.6M Hold
2,472,806
0.09% 53
2025
Q1
$3.19M Hold
2,472,806
0.11% 61
2024
Q4
$6.18M Hold
2,472,806
0.18% 65
2024
Q3
$10M Buy
+2,472,806
New +$9.24M 0.28% 63

Other funds holding ZURA

Braidwell's ZURA Position: Q2 2026 in Review

Braidwell reduced its Zura Bio (ZURA) stake by 0.22% in Q2 2026, selling an estimated $41.4K and leaving 3,980,295 shares worth $23.5M. The position accounts for 0.87% of the portfolio, ranked #47.

Braidwell first reported a position in ZURA in Q3 2024 and has held it in 8 quarters since. The position peaked at $23.7M in Q1 2026. 95 funds tracked by Wall St. Rank hold ZURA as of Q2 2026.

  • Braidwell held 3,980,295 shares of Zura Bio worth $23.5M as of Q2 2026.
  • Braidwell sold 8,694 Zura Bio shares in Q2 2026, an estimated $41.4K.
  • Zura Bio made up 0.87% of Braidwell's portfolio in Q2 2026, its #47 holding.
  • Braidwell first reported a position in Zura Bio in Q3 2024 and has held it in 8 quarters since.
  • Braidwell's Zura Bio position peaked at $23.7M in Q1 2026.
  • 95 funds tracked by Wall St. Rank held Zura Bio as of Q2 2026.

Based on Braidwell's 13F filing for Q2 2026, filed 14 Aug 2026.